Nippon Computer Dynamics: MC MIRI and Reo Fujii to Appear on "COW"
Nippon Computer Dynamics Co.,Ltd (Location: Shinagawa-ku, Tokyo, President: Mr. Osamu Shimojo) will be releasing the promotional video of “COW”, a music co-production platform, ahead of launch of service.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180917005868/en/
MC MIRI of popular idol rap group RHYMEBERRY and Reo Fujii of Omoinotake, so called 3-piece band will be appearing on the promotional video.
“COW” comes from a word “Co-Write” which means to write music in collaboration with someone else. This promotional video shows how splendid works can be produced by creators pulling together.
Released on September 12, 2018
Promotional video of “COW”: https://youtu.be/F1XWTiQuICo
“COW” features creating and producing music and is divided into 4 sections: Track, Melody, Lyrics and Vocal. This music collaboration & songwriting platform that has not ever seen before enables multiple creators to co-write and produce music together. Multiple creators will, by bringing the respective fields of specialty which they have acquired so far, create higher quality music.
Company Name : Nippon Computer Dynamics Co.,Ltd
Establishment : March 1967
Business : IT Business, Parking business for bicycle
President : Mr. Osamu Shimojo
Head Office : 4-32-1, Nishigotanda, Shinagawa-ku, Tokyo, Japan
Webpage : http://www.ncd.co.jp/
Contact for Inquiries
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
DE-INCYTE21.10.2018 12:47 | pressemeddelelse
Incyte Announces Positive Interim Data from Phase 2 Trial of Pemigatinib, Its Selective FGFR Inhibitor, in Patients with Cholangiocarcinoma
SERVIER21.10.2018 11:12 | pressemeddelelse
Servier and Taiho Oncology Announce Phase III LONSURF® Study Has Met Primary and Secondary Endpoints Demonstrating Prolonged Overall Survival and Progression-Free Survival in Patients with Refractory Metastatic Gastric Cancer
IL-GILEAD-SCIENCES21.10.2018 00:32 | pressemeddelelse
Phase 3 Data on Filgotinib in Biologic-Experienced Rheumatoid Arthritis to Be Presented at 2018 ACR/ARHP Annual Meeting
CA-TRUE-RELIGION19.10.2018 19:39 | pressemeddelelse
Manchester United and True Religion Launch Denim Range
ARCH-INSURANCE19.10.2018 15:12 | pressemeddelelse
Arch Insurance Announces Strategic Leadership Changes
MA-TAKEDA-PHARMACEUTICAL19.10.2018 14:02 | pressemeddelelse
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum